header
our approach market research services consulting services planning services
structural heart disease case study clients
medical collage
SPECIAL REPORTS DOCUMENTS
P.O.Box 460664, Fort Lauderdale, FL 33346-0664
Tel: 954-659-8353 • Email:
info@kcipartners.com
 
CASE STUDY
The following case study shows how KCI worked with a large multi-national company to successfully commercialize a game changing medical device technology in a new space (structural heart disease) for the organization. This case study shows many of KCI’s activities that lead to a thorough client understanding of the opportunity, device features and benefits that are driving market share and marketing initiatives that are in development for changing referral patterns.
  arrow circle  
arrow Conducted comprehensive secondary market research to provide basic information on diagnostic/procedure volumes/incidence rates, etc.
arrow Documented the competitive landscape for existing and potential new product entries
arrow Conducted a literature review to document clinical trial results, identify thought leaders and delineate the challenges of treating the disease state
arrow Interviewed key opinion leader (KOL) physicians from US and international markets to develop base line assumptions for market demand and adoption projections
arrow Developed proforma financial statements of revenues and expenses based on market size, market share, revenue and expense assumptions
arrow Interviewed industry personnel and select physicians to understand required clinical performance drivers and device attributes
arrow Interviewed international thought leaders with new technology experience (through clinical trials) to understand procedure challenges, device features and benefits and recommendations for first generation device improvement
arrow Conducted a large scale quantitative study to understand device attributes that will drive
market share
arrow Conducted a large scale quantitative study to understand current referral patterns and requirements to change the patterns upon commercialization of the new technology